Litcius/Paper detail

Empagliflozin Protects against Pulmonary Ischemia/Reperfusion Injury via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent Mechanism

Dou Huang, Feng Ju, Lei Du, Ting Liu, Yunxia Zuo, Geoffrey W. Abbott, Zhaoyang Hu

2021Journal of Pharmacology and Experimental Therapeutics28 citationsDOIOpen Access PDF

Topics & Concepts

Pulmonary edemaEmpagliflozinPharmacologyMedicineIn vivoLungReperfusion injuryIschemiaInternal medicineType 2 diabetesEndocrinologyDiabetes mellitusBiologyBiotechnologyTransplantation: Methods and OutcomesPancreatic function and diabetesDiabetes Treatment and Management
Empagliflozin Protects against Pulmonary Ischemia/Reperfusion Injury via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent Mechanism | Litcius